Your browser doesn't support javascript.
loading
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials.
Talasaz, Azita H; Sadeghipour, Parham; Aghakouchakzadeh, Maryam; Kakavand, Hessam; Ariannejad, Hamid; Connors, Jean M; Hunt, Beverley J; Berger, Jeffrey S; Van Tassell, Benjamin W; Middeldorp, Saskia; Piazza, Gregory; Weitz, Jeffrey I; Cushman, Mary; Lip, Gregory Y H; Goldhaber, Samuel Z; Bikdeli, Behnood.
Affiliation
  • Talasaz AH; Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Sadeghipour P; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Aghakouchakzadeh M; Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Kakavand H; Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Ariannejad H; Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Connors JM; Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Hunt BJ; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Berger JS; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Van Tassell BW; Haemostasis and Thrombosis Centre, St Thomas' Hospital, London, UK.
  • Middeldorp S; Leon H. Charney Division of Cardiology, Department of Medicine, Center for the Prevention of Cardiovascular Disease, New York University School of Medicine, New York, New York, USA.
  • Piazza G; Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Weitz JI; Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Cushman M; Department of Internal Medicine & Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, the Netherlands.
  • Lip GYH; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Goldhaber SZ; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Bikdeli B; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.
J Thromb Haemost ; 19(12): 3080-3089, 2021 12.
Article in En | MEDLINE | ID: mdl-34538017
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Fibrinolytic Agents / COVID-19 Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: Iran
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Fibrinolytic Agents / COVID-19 Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: Iran